Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy
Dirk Rades
*
, Helmut Golke, Steven E. Schild, Ergin Kilic
*
Corresponding author for this work
Clinic of Radiotherapy
University Hospital Hamburg-Eppendorf
Mayo Clinic Scottsdale, AZ
17
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
VEGF Receptor
100%
FLT1
100%
Overall Survival
66%
Hemoglobin Blood Level
16%
Retrospective Study
16%
Erythropoietin
16%
Medicine and Dentistry
Vasculotropin
100%
Overall Survival
66%
Vascular Tissue Neoplasm
33%
Retrospective Study
16%
Neoplasm
16%
Prognostic Factor
16%
Proportional Hazards Model
16%
Subgroup Analysis
16%
Log Rank Test
16%
Kaplan Meier Method
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Overall Survival
66%
Vascular Tumor
33%
Retrospective Study
16%
Neoplasm
16%
Erythropoietin
16%
Immunology and Microbiology
Overall Survival
50%
Hemoglobin
37%
Hemoglobin Blood Level
12%